Literature DB >> 8565318

Tissue-dependent differences in the asynchronous appearance of mast cells in normal mice and in congenic mast cell-deficient mice after infusion of normal bone marrow cells.

T Du1, D S Friend, K F Austen, H R Katz.   

Abstract

The time courses of the appearance of tissue mast cells in six sites were compared in normal WBB6F1(-)+/+ mice (+/+) and in congenic mast cell-deficient WBB6F1-W/Wv mice (W/Wv) that received an intravenous infusion of bone marrow cells from +/+ mice (BM-->W/Wv). As assessed by morphometric analysis of Carnoy's solution-fixed, methylene blue-stained tissue sections, the density of mast cells in the stomach mucosa, stomach submucosa, and spleen of +/+ mice reached maximal levels by 8 weeks of age, whereas the density of mast cells in the skin, extraparenchymal airway walls, and lung parenchyma did not reach maximal levels until 18 weeks of age. When 8-week-old W/Wv mice were infused with 2 x 10(7) bone marrow cells from /+/ mice, mast cells appeared in the stomach mucosa and submucosa after 2.5 weeks, in the spleen and extraparenchymal airway walls after 5 weeks, and in the lung parenchyma after 10 weeks. Twenty weeks after bone marrow infusion, the mast cell densities in the spleen, stomach mucosa, and stomach submucosa were seven-, 13-, and five-fold greater, respectively, than those in age-matched +/+ mice, but were eight-, two-, and five-fold lower in the skin, extraparenchymal airway walls, and lung parenchyma, respectively. Thus, those tissues that in +/+ mice reached maximal mast cell densities earlier exhibited abnormally high mast cell densities in BM-->W/Wv mice, and those that reached maximal mast cell densities later in +/+ mice had abnormally low mast cell densities in BM-->W/Wv mice. Immunological and inflammatory responses are often compared in W/Wv and BM-->W/Wv mice to assess mast cell dependency. Our results indicate that the capacity to restore a mast cell-dependent response in a particular tissue of the latter mice may relate to the local mast cell density and whether the immunological challenge activates mast cells only in that tissue or systemically with attendant widespread release of proinflammatory mediators.

Entities:  

Mesh:

Year:  1996        PMID: 8565318      PMCID: PMC2200335          DOI: 10.1046/j.1365-2249.1996.d01-610.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  5 in total

1.  Mast cell heterogeneity in the gastrointestinal tract: variable expression of mouse mast cell protease-1 (mMCP-1) in intraepithelial mucosal mast cells in nematode-infected and normal BALB/c mice.

Authors:  C L Scudamore; L McMillan; E M Thornton; S H Wright; G F Newlands; H R Miller
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells.

Authors:  Jennine Grootens; Johanna S Ungerstedt; Gunnar Nilsson; Joakim S Dahlin
Journal:  Blood Adv       Date:  2018-09-11

3.  Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis.

Authors:  Albert Dahdah; Gregory Gautier; Tarik Attout; Frédéric Fiore; Emeline Lebourdais; Rasha Msallam; Marc Daëron; Renato C Monteiro; Marc Benhamou; Nicolas Charles; Jean Davoust; Ulrich Blank; Bernard Malissen; Pierre Launay
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

Review 4.  Mast cell progenitor trafficking and maturation.

Authors:  Jenny Hallgren; Michael F Gurish
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  Unique populations of lung mast cells are required for antigen-mediated bronchoconstriction.

Authors:  J M Cyphert; M Kovarova; B H Koller
Journal:  Clin Exp Allergy       Date:  2010-08-16       Impact factor: 5.018

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.